Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,621,612
  • Shares Outstanding, K 28,533
  • Annual Sales, $ 305,450 K
  • Annual Income, $ -52,290 K
  • EBIT $ -14 M
  • EBITDA $ 8 M
  • 60-Month Beta 2.01
  • Price/Sales 7.96
  • Price/Cash Flow 83.28
  • Price/Book 9.45

Options Overview Details

View History
  • Implied Volatility 101.69% ( -4.34%)
  • Historical Volatility 80.69%
  • IV Percentile 72%
  • IV Rank 44.11%
  • IV High 157.37% on 04/07/25
  • IV Low 57.74% on 05/29/25
  • Put/Call Vol Ratio 0.23
  • Today's Volume 874
  • Volume Avg (30-Day) 2,631
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 57,706
  • Open Int (30-Day) 56,202

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.09
  • Number of Estimates 1
  • High Estimate 0.09
  • Low Estimate 0.09
  • Prior Year -0.11
  • Growth Rate Est. (year over year) +181.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
61.55 +41.20%
on 06/18/25
96.00 -9.47%
on 06/25/25
+17.40 (+25.03%)
since 06/10/25
3-Month
55.17 +57.53%
on 05/08/25
117.75 -26.19%
on 04/29/25
-5.71 (-6.16%)
since 04/10/25
52-Week
25.32 +243.25%
on 08/05/24
117.75 -26.19%
on 04/29/25
+55.62 (+177.76%)
since 07/10/24

Most Recent Stories

More News
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains

With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?

WGS : 86.91 (-5.41%)
CDTX : 50.88 (-0.16%)
NKTR : 25.10 (+7.45%)
Why GeneDX Stock Surged Higher This Week

WGS : 86.91 (-5.41%)
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News

The past week has seen a flurry of activity across various sectors, with several small- and mid-cap stocks delivering notable gains and drawing significant investor attention. From healthcare innovators...

WGS : 86.91 (-5.41%)
GEOS : 12.56 (-1.64%)
NNNN : 50.74 (-2.07%)
CDTX : 50.88 (-0.16%)
VERV : 11.06 (-0.27%)
EYEN : 15.82 (+49.81%)
Ensign Enhances Presence With 3 New Acquisitions in 2 States

A leading post-acute care services provider, The Ensign Group Inc. ENSG recently broadened its presence by acquiring three skilled nursing facilities in the U.S. healthcare space. The acquisition includes...

WGS : 86.91 (-5.41%)
ITGR : 121.77 (+1.08%)
ENSG : 145.73 (-0.67%)
CLOV : 3.05 (-3.79%)
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now

Pediatrix Medical Group, Inc. MD is strategically positioned to grow on the back of delivering high-quality, evidence-based care in the healthcare space. The company has gained 5.6% in the year-to-date...

WGS : 86.91 (-5.41%)
ITGR : 121.77 (+1.08%)
MD : 13.50 (-0.44%)
CLOV : 3.05 (-3.79%)
Pediatrix Medical's Q1 Earnings Beat Estimates on Declining Costs

Shares of Pediatrix Medical Group, Inc. MD have risen 11.5% since it reported first-quarter 2025 results on May 6. The quarterly results benefited from strong same-unit revenue growth, improved payor mix...

AVAH : 4.23 (-0.94%)
WGS : 86.91 (-5.41%)
MD : 13.50 (-0.44%)
BTSG : 20.85 (-2.52%)
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit

Shares of Teladoc Health Inc. TDOC have fallen 4.6% since it reported first-quarter 2025 results on April 30, as investors are not impressed with its 2025 outlook. Although it reported better-than-expected...

AVAH : 4.23 (-0.94%)
WGS : 86.91 (-5.41%)
TDOC : 8.81 (-0.45%)
BTSG : 20.85 (-2.52%)
Best Momentum Stocks to Buy for May 5th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 5th:GeneDx Holdings Corp. WGS: This genomics-related diagnostic and information services company...

WGS : 86.91 (-5.41%)
CBNK : 35.36 (+0.28%)
EBMT : 17.47 (-0.11%)
Why Investors Were Avoiding GeneDx Holdings Stock This Week

With a nearly 39% stock price decline this week, according to data compiled by S&P Global Market Intelligence, GeneDx Holdings (NASDAQ: WGS) was deep in the doghouse with investors. They traded out of...

NFLX : 1,250.59 (-2.93%)
WGS : 86.91 (-5.41%)
Why GeneDx Holdings Stock Is Plunging Today

Shares of GeneDx Holdings (NASDAQ: WGS) were plunging 42.9% as of 11:21 a.m. ET on Wednesday. The steep decline came after the genetic diagnostics company announced its 2025 first-quarter earnings before...

NFLX : 1,250.59 (-2.93%)
WGS : 86.91 (-5.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 101.31
2nd Resistance Point 97.43
1st Resistance Point 94.65
Last Price 86.91
1st Support Level 88.00
2nd Support Level 84.11
3rd Support Level 81.34

See More

52-Week High 117.75
Last Price 86.91
Fibonacci 61.8% 82.44
Fibonacci 50% 71.54
Fibonacci 38.2% 60.63
52-Week Low 25.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar